Gastric Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Apr 15, 2003; 9(4): 665-669
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.665
Table 1 Relationship between ER, ERmRNA expression and pathology in gastric cancer
PathologyMale
Female
Total
nER (+)%ERmRNA (+)%nER (+)%ERmRNA (+)%nER (+)%ERmRNA (+)%
Borrmann I3133.3133.3300266.76116.7350.0
II4125.0375.04250.0375.08337.5675.0
III4125.0375.04250.04100.08337.5787.5
IV4250.04100.04375.04100.08562.58100.0
Papillary100001000020000
Tubular600466.76116.7588.31218.31083.3
Poorly differentiated7457.1685.76466.76100.013861.51184.6
Signet ring cell11100.01100.022100.02100.033100.03100.0
Nondiffused9222.2666.75120.0480.014321.41071.4
Diffused6350.0583.310660.0990.016956.31487.5
Lymph node 0300133.3400375.0700457.1
Involvemen ≤ 34125.0375.05360.0480.09444.4777.8
4~66233.3583.35360.05100.011545.51090.9
> 622100.02100.011100.01100.033100.03100.0
Age ≤ 556350.0466.79333.3777.815640.01173.3
> 559222.2777.86466.76100.015640.01386.7
Total15533.31173.315746.71386.7301240.02480.0